Recent Updates
Recently added Catalysts
DCTH Positive Sentiment Score: 70/100

Delcath Systems to Host Second Quarter 2026 Earnings Call

Thursday, July 23, 2026 1 min read
Key Takeaway: Delcath Systems, an interventional oncology company, announced it will host an earnings call on August 6, 2026, to discuss its second quarter results. The call is scheduled for 8:30 AM Eastern Time. This event highlights the company's ongoing commitment to transparency and investor engagement.

Market Sentiment Analysis

POSITIVE FACTORS

  • Delcath Systems is actively engaging with investors.
  • The earnings call indicates transparency in financial performance.
  • Focus on interventional oncology shows commitment to cancer treatment.

Full Press Release Details

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on August 6, 2026, at 8:30 AM Eastern Time to discuss results for its second quarter ended June 30, 2026. Conference Call Information To participate in this event, dial in approximately 5 to 10 minutes before the beginning of the call. Event Date: Thursday, August 6, 202

Frequently Asked Questions

When is the Delcath Systems earnings call?

The earnings call is scheduled for August 6, 2026, at 8:30 AM Eastern Time.

How can I participate in the earnings call?

To participate, dial in approximately 5 to 10 minutes before the call starts.

What will be discussed during the earnings call?

The call will discuss Delcath Systems' financial results for the second quarter of 2026.

Tags: DCTH Viatris Investor Conferences Healthcare Delcath Systems earnings call interventional oncology cancer treatment
Last updated: Jul 23, 2026

Biotech snapshot

Cash runway
$89M liquidity · $0M/mo burn
Low dilution risk
Lead asset
Trifluridine-tipiracil plus Bevacizumab AlonePhase 2
Refractory Metastatic Colorectal Cancer →

Catalyst track record

+154%
best trade around DCTH's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for DCTH.

See every catalyst's timing & PoA →